Cargando…

Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study

Idiopathic dilated cardiomyopathy (DCM) is a common cardiomyopathy with the prevalence of 1:250, and at least one-third of all the cases are inherited. Mutations in the TTN gene are considered as the most frequent cause of inherited DCM and cover 10–30% of the cases. The studies were mainly focused...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaklyazminskaya, Elena, Mikhailov, Vadim, Bukaeva, Anna, Kotlukova, Natalia, Povolotskaya, Inna, Kaimonov, Vladimir, Dombrovskaya, Anna, Dzemeshkevich, Sergey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848193/
https://www.ncbi.nlm.nih.gov/pubmed/31712709
http://dx.doi.org/10.1038/s41598-019-52911-1
_version_ 1783469043589578752
author Zaklyazminskaya, Elena
Mikhailov, Vadim
Bukaeva, Anna
Kotlukova, Natalia
Povolotskaya, Inna
Kaimonov, Vladimir
Dombrovskaya, Anna
Dzemeshkevich, Sergey
author_facet Zaklyazminskaya, Elena
Mikhailov, Vadim
Bukaeva, Anna
Kotlukova, Natalia
Povolotskaya, Inna
Kaimonov, Vladimir
Dombrovskaya, Anna
Dzemeshkevich, Sergey
author_sort Zaklyazminskaya, Elena
collection PubMed
description Idiopathic dilated cardiomyopathy (DCM) is a common cardiomyopathy with the prevalence of 1:250, and at least one-third of all the cases are inherited. Mutations in the TTN gene are considered as the most frequent cause of inherited DCM and cover 10–30% of the cases. The studies were mainly focused on the adult or mixed age group of patients with DCM. The mutation rate in the TTN gene, the characteristics of manifestations and their prognostic significance in childhood have not been studied. To determine TTN mutation rate in children with DCM and the relevance of including this gene in the DNA diagnostic protocol for paediatric DCM, complete clinical and instrumental examination of 36 DCM patients (up to 18 years) with the manifestation of the disease was conducted in specialised cardiology centres. Molecular genetic testing included sequencing of coding and adjacent regulatory regions of the major cardiac TTN isoform N2BA using IonTorrent ™ semiconductor sequencing (for 25 isolated cases) and trio whole exome sequencing (trio WES)on the Illumina platform (for 11 family cases). Our pilot group included 36 probands with DCM diagnosis first established on the basis of the generally accepted criteria at the age of 5 days to 18 years(average age: 6.5 years). The sex ratio (M:F) was 23: 8. There were 25 sporadic DCM cases and 11 cases of familial DCM (at least one of the parents and/or siblings were also diagnosed with DCM). The only likely pathogenic truncating variant p.Arg33703*in the TTN gene (TTNtv) was found in a 16-year-oldmale proband out of 36 (3%). Apparently, TTN-dependent forms of DCMs manifest later at a young (but older than 18 years) or more mature age, and TTN gene cannot be considered as the first-line genetic testing for DCM in the paediatric group, despite several studies have reported a generally high mutation rate in this gene with DCM. Further research is needed to compare the representation of mutations in the TTN gene in different age groups of DCM patients.
format Online
Article
Text
id pubmed-6848193
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68481932019-11-19 Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study Zaklyazminskaya, Elena Mikhailov, Vadim Bukaeva, Anna Kotlukova, Natalia Povolotskaya, Inna Kaimonov, Vladimir Dombrovskaya, Anna Dzemeshkevich, Sergey Sci Rep Article Idiopathic dilated cardiomyopathy (DCM) is a common cardiomyopathy with the prevalence of 1:250, and at least one-third of all the cases are inherited. Mutations in the TTN gene are considered as the most frequent cause of inherited DCM and cover 10–30% of the cases. The studies were mainly focused on the adult or mixed age group of patients with DCM. The mutation rate in the TTN gene, the characteristics of manifestations and their prognostic significance in childhood have not been studied. To determine TTN mutation rate in children with DCM and the relevance of including this gene in the DNA diagnostic protocol for paediatric DCM, complete clinical and instrumental examination of 36 DCM patients (up to 18 years) with the manifestation of the disease was conducted in specialised cardiology centres. Molecular genetic testing included sequencing of coding and adjacent regulatory regions of the major cardiac TTN isoform N2BA using IonTorrent ™ semiconductor sequencing (for 25 isolated cases) and trio whole exome sequencing (trio WES)on the Illumina platform (for 11 family cases). Our pilot group included 36 probands with DCM diagnosis first established on the basis of the generally accepted criteria at the age of 5 days to 18 years(average age: 6.5 years). The sex ratio (M:F) was 23: 8. There were 25 sporadic DCM cases and 11 cases of familial DCM (at least one of the parents and/or siblings were also diagnosed with DCM). The only likely pathogenic truncating variant p.Arg33703*in the TTN gene (TTNtv) was found in a 16-year-oldmale proband out of 36 (3%). Apparently, TTN-dependent forms of DCMs manifest later at a young (but older than 18 years) or more mature age, and TTN gene cannot be considered as the first-line genetic testing for DCM in the paediatric group, despite several studies have reported a generally high mutation rate in this gene with DCM. Further research is needed to compare the representation of mutations in the TTN gene in different age groups of DCM patients. Nature Publishing Group UK 2019-11-11 /pmc/articles/PMC6848193/ /pubmed/31712709 http://dx.doi.org/10.1038/s41598-019-52911-1 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Zaklyazminskaya, Elena
Mikhailov, Vadim
Bukaeva, Anna
Kotlukova, Natalia
Povolotskaya, Inna
Kaimonov, Vladimir
Dombrovskaya, Anna
Dzemeshkevich, Sergey
Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study
title Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study
title_full Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study
title_fullStr Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study
title_full_unstemmed Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study
title_short Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study
title_sort low mutation rate in the ttn gene in paediatric patients with dilated cardiomyopathy – a pilot study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848193/
https://www.ncbi.nlm.nih.gov/pubmed/31712709
http://dx.doi.org/10.1038/s41598-019-52911-1
work_keys_str_mv AT zaklyazminskayaelena lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy
AT mikhailovvadim lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy
AT bukaevaanna lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy
AT kotlukovanatalia lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy
AT povolotskayainna lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy
AT kaimonovvladimir lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy
AT dombrovskayaanna lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy
AT dzemeshkevichsergey lowmutationrateinthettngeneinpaediatricpatientswithdilatedcardiomyopathyapilotstudy